AGC Biologics Milan specializes in cell therapy and viral vector development and manufacturing. The site works with virtually any cell type and lentiviral, retroviral, and adeno‐associated viral vectors.
The facility was the first cell and gene therapy site approved in Europe for GMP manufacturing of clinical and commercial supplies. The core scientific team has 25 years of expertise in the field and unique knowledge you will not find anywhere else.
The Milan team has developed 3 commercial products including, before joining the AGC network, brought its own product to the market (Zalmoxis®). This experience means they understand the processes, procedures, and painstaking work involved in developing and bringing these treatments to market.